Problems and Solutions in the Evaluation of Hormone Receptors in Breast Cancer-Reference-Cited by-同舟云学术

Problems and Solutions in the Evaluation of Hormone Receptors in Breast Cancer

Published:2008-05-20 Issue:15 Volume:26 Page:2433-2435
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Allred D. Craig¹

Affiliation:

1. Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.15.7800

Reference25 articles.

1. Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

2. E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer

3. Allred DC, Harvey JM, Berardo MD, et al: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155,1998-168,

4. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

5. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature;Breast Cancer Research and Treatment;2023-02-21

2. Prognostic impact of miR-125b and miR-155b and their relationship with <i>MYC</i> and <i>TP53</i> in diffuse large B-cell lymphoma: cell-of-origin classification matters;Journal of Clinical and Experimental Hematopathology;2023

3. Updated CAP guidelines for determining molecular biological subtypes of breast cancer;Arkhiv patologii;2023

4. Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer;Medicina;2022-12-30

5. Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers;Medicina;2022-09-13